460 related articles for article (PubMed ID: 22710176)
41. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Tan AR; Alexe G; Reiss M
Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
[TBL] [Abstract][Full Text] [Related]
42. Ubiquitin-dependent regulation of TGFbeta signaling in cancer.
Izzi L; Attisano L
Neoplasia; 2006 Aug; 8(8):677-88. PubMed ID: 16925950
[TBL] [Abstract][Full Text] [Related]
43. Adaptive immune responses associated with breast cancer relapse.
Payne KK; Manjili MH
Arch Immunol Ther Exp (Warsz); 2012 Oct; 60(5):345-50. PubMed ID: 22911133
[TBL] [Abstract][Full Text] [Related]
44. Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer.
Chattopadhyay I; Ambati R; Gundamaraju R
Mediators Inflamm; 2021; 2021():9918379. PubMed ID: 34220337
[TBL] [Abstract][Full Text] [Related]
45. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression.
Mishra VK; Johnsen SA
Cell Tissue Res; 2014 Jun; 356(3):617-30. PubMed ID: 24833164
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes.
Fuxe J; Vincent T; Garcia de Herreros A
Cell Cycle; 2010 Jun; 9(12):2363-74. PubMed ID: 20519943
[TBL] [Abstract][Full Text] [Related]
47. TGFβ: A player on multiple fronts in the tumor microenvironment.
Caja F; Vannucci L
J Immunotoxicol; 2015; 12(3):300-7. PubMed ID: 25140864
[TBL] [Abstract][Full Text] [Related]
48. Epithelial-mesenchymal transition (EMT): principles and clinical impact in cancer therapy.
Franco-Chuaire ML; Magda Carolina SC; Chuaire-Noack L
Invest Clin; 2013 Jun; 54(2):186-205. PubMed ID: 23947008
[TBL] [Abstract][Full Text] [Related]
49. TGFbeta-regulated transcriptional mechanisms in cancer.
Ellenrieder V; Buck A; Gress TM
Int J Gastrointest Cancer; 2002; 31(1-3):61-9. PubMed ID: 12622416
[TBL] [Abstract][Full Text] [Related]
50. Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy.
Chen J; Ding ZY; Li S; Liu S; Xiao C; Li Z; Zhang BX; Chen XP; Yang X
Theranostics; 2021; 11(3):1345-1363. PubMed ID: 33391538
[TBL] [Abstract][Full Text] [Related]
51. TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.
Howley BV; Howe PH
Cytokine; 2019 Jun; 118():19-26. PubMed ID: 29396052
[TBL] [Abstract][Full Text] [Related]
52. Alternative splicing in EMT and TGF-β signaling during cancer progression.
Zhang YE; Stuelten CH
Semin Cancer Biol; 2024 Jun; 101():1-11. PubMed ID: 38614376
[TBL] [Abstract][Full Text] [Related]
53. TGFβ signaling networks in ovarian cancer progression and plasticity.
Kumari A; Shonibare Z; Monavarian M; Arend RC; Lee NY; Inman GJ; Mythreye K
Clin Exp Metastasis; 2021 Apr; 38(2):139-161. PubMed ID: 33590419
[TBL] [Abstract][Full Text] [Related]
54. 3'-UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end.
Chaudhury A; Hussey GS; Howe PH
RNA Biol; 2011; 8(4):595-9. PubMed ID: 21654215
[TBL] [Abstract][Full Text] [Related]
55. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.
Waerner T; Alacakaptan M; Tamir I; Oberauer R; Gal A; Brabletz T; Schreiber M; Jechlinger M; Beug H
Cancer Cell; 2006 Sep; 10(3):227-39. PubMed ID: 16959614
[TBL] [Abstract][Full Text] [Related]
56. The regulation of cell polarity in the progression of lung cancer.
Liu Y; Chen LP
J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S80-5. PubMed ID: 24135247
[TBL] [Abstract][Full Text] [Related]
57. The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma.
Ramundo V; Zanirato G; Aldieri E
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830097
[TBL] [Abstract][Full Text] [Related]
58. TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer.
Hua W; Ten Dijke P; Kostidis S; Giera M; Hornsveld M
Cell Mol Life Sci; 2020 Jun; 77(11):2103-2123. PubMed ID: 31822964
[TBL] [Abstract][Full Text] [Related]
59. Mutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR.
Schuhwerk H; Brabletz T
Semin Cancer Biol; 2023 Dec; 97():86-103. PubMed ID: 38029866
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer.
Gottumukkala SB; Ganesan TS; Palanisamy A
NPJ Syst Biol Appl; 2024 May; 10(1):53. PubMed ID: 38760412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
